/PRNewswire/ Tenneco Inc. (NYSE: TEN) will participate in the 2021 Deutsche Bank Global Auto Industry Conference to be held virtually on Thursday, June 17,.
Share this article
Share this article
NEW BRUNSWICK, N.J., June 9, 2021 /PRNewswire/ Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at
8:30 a.m. (Eastern Time) on Wednesday, July 21
stto review second-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Christopher DelOrefice, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include Alex Gorsky, Chairman and Chief Executive Officer.
Investors and other interested parties can access the webcast/conference call in the following ways:
The webcast and presentation material are accessible at Johnson & Johnson s website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
About the MicroCap Rodeo Summer Solstice Best Ideas Conference
The MicroCap Rodeo is back with its third Best Ideas Bowl. This conference is a virtual conference that brings you the top 35 best ideas from the buy side. Qualified institutional investors recommended each of the 35 companies represented as one of their best ideas. Those of you who attended the 2019 MicroCap Rodeo in Austin, Texas, know that we re focused on alpha. To receive additional information, request an invitation or to schedule a one-on-one meeting, please email to:[email protected].
About Miravo Healthcare
Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company s products target several therapeutic areas, including pain, allergy, neurology and dermatology. The Company s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo s head office is located in Missis
/PRNewswire/ Acorns Grow Incorporated ("Acorns"), the saving and investing app, has entered into a definitive business combination agreement with Pioneer.
Viracta Therapeutics to Present at the Jefferies Virtual Healthcare Conference
News provided by
Share this article
SAN DIEGO, May 27, 2021 /PRNewswire/
Viracta Therapeutics, Inc. (Viracta or the Company), a precision oncology company targeting virus-associated malignancies, today announced that Company management will present at the Jefferies Virtual Healthcare Conference taking place June 1-4, 2021. The Company will also participate in one-on-one investor meetings at the conference.
Details on the presentation can be found below.
Date:
About Viracta Therapeutics, Inc.
Viracta is a precision oncology company targeting virus-associated malignancies. Viracta s proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in a Phase 2 clinical trial for EBV-positive lymphoma. Viracta is pursuing application of this inducible synthetic lethality approach in other EBV-associat